Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $312000.0.

  • Assembly Biosciences' Other Non-Current Assets changed 0.0% to $312000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $312000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $312000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Assembly Biosciences' Other Non-Current Assets stood at $312000.0, which was down 0.0% from $312000.0 recorded in Q2 2025.
  • Assembly Biosciences' 5-year Other Non-Current Assets high stood at $6.1 million for Q2 2021, and its period low was $312000.0 during Q4 2023.
  • In the last 5 years, Assembly Biosciences' Other Non-Current Assets had a median value of $334000.0 in 2023 and averaged $1.4 million.
  • In the last 5 years, Assembly Biosciences' Other Non-Current Assets soared by 26327.51% in 2021 and then plummeted by 8464.37% in 2023.
  • Over the past 5 years, Assembly Biosciences' Other Non-Current Assets (Quarter) stood at $1.7 million in 2021, then plummeted by 47.8% to $889000.0 in 2022, then tumbled by 64.9% to $312000.0 in 2023, then changed by 0.0% to $312000.0 in 2024, then changed by 0.0% to $312000.0 in 2025.
  • Its Other Non-Current Assets was $312000.0 in Q3 2025, compared to $312000.0 in Q2 2025 and $312000.0 in Q1 2025.